Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Topic 11: T Cell Immunity<br />
P11.<strong>01</strong><br />
Evaluation of the Dual IFNγ/IL-2 Fluorospot-Assay<br />
with Flow Cytometry For Detection of HLA-Restricted<br />
<strong>HIV</strong>-Specific T-Cell Responses in <strong>HIV</strong> Controllers<br />
N. Keane 1 , C. Almeida 1 , S. Roberts 1 , I. Ahmad 1 , S. Mallal 1 ,<br />
M. John 1<br />
1 Murdoch University, Perth, Australia<br />
Background: The IFNγ ELISpot assay is used widely for high<br />
through-put screening of <strong>HIV</strong>-specific responses in studies of<br />
<strong>HIV</strong> infection and vaccine studies. However, dual production of<br />
IFN/IL-2 and increased proliferative capacity may be associated<br />
with better natural control of <strong>HIV</strong> infection. We evaluated a<br />
novel fluorospot assay enabling the identification of dual IFNγ/<br />
IL-2 producing antigen-specific cells and compared it with<br />
intracellular cytokine staining by standard flow cytometry in<br />
individuals with natural control of <strong>HIV</strong>-infection.<br />
Methods: PBMC from five untreated <strong>HIV</strong>-infected individuals<br />
were stimulated overnight with <strong>HIV</strong> peptides or controls in<br />
dual IFN/IL-2 pre-coated plates. Peptide arrays were specifically<br />
selected based on the individual HLA type. Secreted IFNγ and<br />
IL-2 were detected using fluorescent-conjugated antibodies.<br />
Fluorescent spots were enumerated on the iSpot AID reader.<br />
Responses were considered positive if >50 spots/million cells<br />
SFU after background subtraction.Positive responses were then<br />
evaluated by flow cytometry using the Gallios flow cytometer.<br />
Results: Dual IL-2/IFNγ producing cells were detected to anti-CD3stimulated<br />
PBMC from all patients. IFNγ responses alone were<br />
detected to 35 of 136 HLA-restricted peptides tested (median<br />
=73, 52-4190 SFU) across the 5 patients (1/19, 5/19, 7/28, 9/15<br />
and 13/55 for each patient), while IL-2 responses were either low<br />
grade or undetectable for the majority of <strong>HIV</strong> peptides tested.<br />
Dual IFNγ/IL-2 producing <strong>HIV</strong>-specific T cells were not detected<br />
using the fluorospot assay. 24/35 peptides induced CD8 T cell-<br />
IFNγ production by flow cytometry.<br />
Conclusion: <strong>HIV</strong>-specific mono-IFNγ responses were detected<br />
using the novel fluorospot assay. However limited <strong>HIV</strong>-specific dual<br />
IFNγ/IL-2 responses were detected in this patient group. A greater<br />
number of epitope-specific positive responses were detected<br />
in the fluorospot compared with flow cytometry suggesting the<br />
fluorospot may be more sensitive in detecting a greater breadth<br />
of epitope-specific T cell responses, and therefore better for<br />
screening purposes than flow cytometric methods.<br />
P11.02<br />
AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />
Posters<br />
Early Changes in the CD8 T Cell Immunodominance<br />
Hierarchy in Primary <strong>HIV</strong> Infection Prior to<br />
Seroconversion<br />
N. Keane 1 , C. Almeida 1 , A. Chopra 1 , D. Cooper 1 , E. Demaine 1 ,<br />
S. Mallal 1 , M. John 1<br />
1 Murdoch University, Perth, Australia<br />
Background: Identification of the earliest CD8 T-cell responses<br />
against <strong>HIV</strong> may help select critical viral targets for inclusion in<br />
an <strong>HIV</strong> vaccine. We describe changes to the earliest detected<br />
CD8 T-cell responses and changes in genetic sequence encoding<br />
targeted epitopes in an individual who presented with Fiebig stage<br />
II, clade C acute <strong>HIV</strong>-infection, 27 days after sexual transmission.<br />
Methods: We examined HLA-restricted CD8 T-cell responses by<br />
IFNγ ELISpot and <strong>HIV</strong> Gag, Pol, Nef and Env sequence by 454<br />
deep sequencing over 6 timepoints, from days 27-118 after<br />
<strong>HIV</strong>-transmission. <strong>HIV</strong>-specific IFNγ responses were detected<br />
against ten <strong>HIV</strong> epitopes in Gag, Nef and Env at day 27 post <strong>HIV</strong>transmission<br />
when the patient’s CD4 T-cell count was at a nadir<br />
of 224 cells/_l, the plasma <strong>HIV</strong> RNA >106 copies/ml and prior to<br />
any detectable p24 antibody.<br />
Results: Immunodominant responses were detected to the<br />
HLA-B*07:02 restricted Env IIRRIRQGL (IL9) epitope and<br />
the B*07:02 Gag GPGHKARVL (GL9) epitope (>4000SFU). A<br />
detectable but weaker response was observed to HLA-B*08 Nef<br />
FLKEKGGL (FL8) epitope (1<strong>01</strong>0SFU). These responses declined<br />
over subsequent timepoints to 470 and 1630SFU on day 118<br />
coincident with a 2 log fall in the plasma viral load, a rise in the<br />
CD4 T cell count to 533 cells/µL and antibody seroconversion.<br />
The Nef FL8 became the immunodominant response after day<br />
34. IFN_ responses broadened from 10 responses at day 27 to<br />
23 responses by day 118. Analysis of Gag, Nef and Pol genes by<br />
454 deep sequencing showed no evidence of escape within the<br />
targeted epitopes as a cause of their decline over time.<br />
Conclusion: Early changes in the CD8 T-cell immunodominance<br />
hierarchy are apparent in acute <strong>HIV</strong>-infection prior to<br />
seroconversion, including early immunodominant targeting of<br />
Env epitopes. Subsequent broadening of the CD8 T-cell response<br />
was not associated with CD8 T-cell escape in this case.<br />
217<br />
POSTERS